Live Breaking News & Updates on Signet Healthcare Partners|Page 4
Stay updated with breaking news from Signet healthcare partners. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ascendia Pharmaceuticals Secures Growth Equity Investment from Signet Healthcare Partners News provided by Share this article Share this article NORTH BRUNSWICK, N.J., April 8, 2021 /PRNewswire/ Based in North Brunswick, NJ, Ascendia Pharmaceuticals, Inc. ( Ascendia ) is a specialty contract development and manufacturing organization (CDMO) dedicated to developing and manufacturing enhanced formulations for pre-clinical, clinical stage drug candidates, and marketed drug products. The investment was made by Signet Healthcare Partners ( Signet ), a New York-based growth equity firm specializing in healthcare investments. The proceeds will be used to fund Ascendia s facility expansion to support the growing demand in the sector. Founded in 2012, Ascendia offers a comprehensive suite of pre-formulation, formulation development, manufacturing, and stability services for parental, oral, and topical dosage forms. The Company also provides analytical method developme ....
End of Year Update: 2020 Life Science Venture Capital Funding Roundup in the BioHealth Capital Region This has certainly been a year unlike any other for BioHealth Capital Region (BHCR) life science companies of all sizes and kinds. Just a few months into 2020, the coronavirus pandemic swept the region, seriously disrupting, albeit temporarily, the best-laid plans of aspiring founders, entrepreneurs, emerging startups, pre-clinical and more established, larger biohealth organizations in Virginia, Washington, D.C., and Maryland. The regional life science ecosystem was prepared and pivoted rapidly to not only ensure continued operations, but also to redirect resources, talent and technologies to creating testing, developing COVID-19 therapies and progressing SARS-CoV-2 vaccine candidates. ....